It was in July 2018 when the Union Cabinet, chaired by Prime Minister
Narendra Modi, approved the DNA Technology (Use and Application)
Regulation Bill, 2018.
![]() | ||||||
| Winter Session Of Parliament: PTI |
But it was on Tuesday that the landmark decision was successfully
passed in the Lok Sabha — a big step towards the regulation and use of
Deoxyribonucleic Acid (DNA) technology in identifying missing persons,
victims, offenders, people under trial and unknown or deceased people in
the country.
The Bill will also expand the use of DNA-based forensic technologies
to support and strengthen the system of delivering justice in India.
Indeed, the passing of this Bill is a huge success for the country as it
will allow the so-called “digital era” or technology-enabled era to
flourish further.
Using technology to pinpoint the identity of people in matters of
crime, parentage disputes, emigration or immigration and organ
transplant will add considerable speed to the case at hand.
In India, regulation is missing at all levels, across all sectors. By
providing for a mandatory accreditation and regulation of DNA
laboratories, the Bill seeks to ensure that the expanded use of this
technology in the country grows alongside assurances of reliable DNA
test results. Furthermore, the data from these tests — to be stored in
DNA data banks — remains protected from misuse or abuse as far as the
privacy rights of Indian citizens are concerned.
The consent and privacy clauses in the bill are yet to be elaborated
upon. Important things that the Bill's hasn't clearly stated
includes conditions under which consent would and wouldn’t be required
- when a DNA sample needs to be obtained,
- when informing someone that their DNA sample has been included in the database,
- when a person is allowed to appeal for the collection of his/her DNA data
DNA has become an important, crucial tool in solving crimes. It is
important that there are safeguards to protect human rights and prevent
miscarriages of justice in the process.
The Bill lists national and regional DNA data banks that will be
established and the collected data maintained in indices, including
crime scene index, suspects’ or undertrials’ index and offenders’ index.
It is yet to define if this will be a powerful, insufficiently
transparent, or accountable body overseeing the process.
There
is a need to set up an independent ethics board to monitor key
processes of the data banks and ensure that they are not been misused by
investigative agencies while the DNA samples are being collected.
Creating large databases is rarely a cost-effective approach to
crime-solving. There are still a lot of unknowns, one of them
being a concentration of the benefits from the Bill in the hands of the haves.
Uneven technological capability and awareness countrywide is not a new
problem, but will apply differently to different investigative agencies
in the country.
Also in need of some clarity are some of the finer details of the process: Will the conflicts of interest be published for each board member when appointed? Will they be updated on an ongoing basis? Will all the board proceedings also be published?By passing The Constitution (One Hundred And Twenty-Fourth Amendment) Bill, 2019, we pay tributes to the makers of our Constitution and the great freedom fighters, who envisioned an India that is strong and inclusive.
— Narendra Modi (@narendramodi) January 9, 2019
It is also not clear from the Bill whether the collected samples of DNA will also be used to resolve civil disputes.
A number of privacy protections appear to be missing from the Bill.
These include the need to restrict DNA profiling so that it uses only
non-coding DNA — which remain silent and unused in everyday functioning
and maintenance by the body. Sequences of non-coding DNA house markers,
or identifiers, that are unique to every individual, and can tell two
people apart with ease. It also has other sequences that can code for
diseases, personal characteristics and medical conditions. Restricting
DNA profiling to just non-coding DNA in a commonly-used international
standard for the procedure, preventing the use of DNA profiling
technology to reveal personal information that can be misused.
All said and done, some important safeguards and cost-benefit
analysis are still lacking for the Bill, which over time will need
strong bridges across stakeholders, along with a system of monitoring
for the authorities that are monitoring and regulating the technology's
use and applications.
The author is co-founder and Managing Director of Cloudnine Group of Hospitals.
